Advertisement
Journal of Clinical Oncology  
Search for:
Limit by:
  Browse by Subject or Issue
Home Search or Browse JCO My JCO Subscriptions Customer Service Site Map

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a colleague
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Save to my personal folders
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Yamamoto, S.
Right arrow Articles by Aozasa, K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Yamamoto, S.
Right arrow Articles by Aozasa, K.
Journal of Clinical Oncology, Vol 21, Issue 13 (July), 2003: 2537-2544
© 2003 American Society for Clinical Oncology

Expression Level of Valosin-Containing Protein Is Strongly Associated With Progression and Prognosis of Gastric Carcinoma

Shinji Yamamoto, Yasuhiko Tomita, Yoshihiko Hoshida, Shuji Takiguchi, Yoshiyuki Fujiwara, Takushi Yasuda, Masahiko Yano, Shoji Nakamori, Masato Sakon, Morito Monden, Katsuyuki Aozasa

From the Departments of Surgery and Clinical Oncology, and Pathology, Osaka University Graduate School of Medicine, Osaka, Japan.

Address reprint requests to Yasuhiko Tomita, MD, Department of Pathology (C3), Osaka University Graduate School of Medicine, 2-2 Yamadaoka, Suita Osaka 565-0871, Japan; email: yt{at}molpath.med.osaka-u.ac.jp.

Purpose: Valosin-containing protein (VCP; also known as p97) was shown to be associated with antiapoptotic function and metastasis via activation of nuclear factor kappa-B signaling pathway. In this study, association of VCP expression with recurrence of gastric carcinoma (GC), in which lymphatic vessels are the main route of spread, was examined.

Patients and Methods: VCP expression in 330 patients with GC (242 males and 88 females) with ages ranging from 26 to 81 years (median, 60 years) was analyzed by immunohistochemistry, in which staining intensity in tumor cells was categorized as weaker (level 1) or equal to or stronger (level 2) than that in endothelial cells.

Results: Ninety-four (28.7%) patient cases showed level 1 and 233 patient cases (71.3%) showed level 2 VCP expression. Patients with level 2 expression showed higher rates of large tumor size (P < .0001), undifferentiated histologic subtype (P < .05), presence of vascular and lymphatic invasion (P < .0001 for both), presence of lymph node metastasis (P < .0001), deep tumor invasion (P < .0001), and poorer disease-free and overall survivals (P < .0001 for both) compared with those with level 1 VCP expression. Multivariate analysis revealed VCP expression level as an independent prognosticator for disease-free and overall survival. VCP level was an indicator for disease-free and overall survival in the early (pT1; P < .01 and P < .05, respectively) and advanced (pT2–4; P < .05 for both) group of pathologic tumor-node-metastasis system classification.

Conclusion: The prognostic significance of VCP expression level in GC was demonstrated.




This article has been cited by other articles:


Home page
Am. J. Pathol.Home page
Y. Qiu, Y. Tomita, B. Zhang, I. Nakamichi, E. Morii, and K. Aozasa
Pre-B-Cell Leukemia Transcription Factor 1 Regulates Expression of Valosin-Containing Protein, a Gene Involved in Cancer Growth
Am. J. Pathol., January 1, 2007; 170(1): 152 - 159.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. Noguchi, T. Takata, Y. Kimura, A. Manno, K. Murakami, M. Koike, H. Ohizumi, S. Hori, and A. Kakizuka
ATPase Activity of p97/Valosin-containing Protein Is Regulated by Oxidative Modification of the Evolutionally Conserved Cysteine 522 Residue in Walker A Motif
J. Biol. Chem., December 16, 2005; 280(50): 41332 - 41341.
[Abstract] [Full Text] [PDF]


Home page
Ann. Surg. Oncol.Home page
S. Yamamoto, Y. Tomita, T. Uruno, Y. Hoshida, Y. Qiu, N. Iizuka, I. Nakamichi, A. Miyauchi, and K. Aozasa
Increased Expression of Valosin-Containing Protein (p97) Is Correlated With Disease Recurrence in Follicular Thyroid Cancer
Ann. Surg. Oncol., November 1, 2005; 12(11): 925 - 934.
[Abstract] [Full Text] [PDF]


Home page
Ann OncolHome page
S. Yamamoto, Y. Tomita, Y. Hoshida, S. Toyosawa, H. Inohara, M. Kishino, M. Kogo, M. Nakazawa, S. Murakami, N. Iizuka, et al.
Expression level of valosin-containing protein (VCP) as a prognostic marker for gingival squamous cell carcinoma
Ann. Onc., September 1, 2004; 15(9): 1432 - 1438.
[Abstract] [Full Text] [PDF]


Home page
Ann. Surg. Oncol.Home page
S. Yamamoto, Y. Tomita, Y. Hoshida, N. Iizuka, M. Monden, S. Yamamoto, K. Iuchi, and K. Aozasa
Expression Level of Valosin-Containing Protein (p97) Is Correlated With Progression and Prognosis of Non-Small-Cell Lung Carcinoma
Ann. Surg. Oncol., July 1, 2004; 11(7): 697 - 704.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
Y. Tsujimoto, Y. Tomita, Y. Hoshida, T. Kono, T. Oka, S. Yamamoto, N. Nonomura, A. Okuyama, and K. Aozasa
Elevated Expression of Valosin-Containing Protein (p97) Is Associated with Poor Prognosis of Prostate Cancer
Clin. Cancer Res., May 1, 2004; 10(9): 3007 - 3012.
[Abstract] [Full Text] [PDF]



About
JCO
 Editorial
Roster
 Advertising
Information
 Librarians &
Institutions
 Rights &
Permissions
 PDA Services

Copyright © 2003 by the American Society of Clinical Oncology, Online ISSN: 1527-7755. Print ISSN: 0732-183X
Terms and Conditions of Use
  HighWire Press HighWire Press™ assists in the publication of JCO Online